Suppression of type I IFN signaling in tumors mediates resistance to anti-PD-1 treatment that can be overcome by radiotherapy

Immune checkpoint therapies exhibit impressive efficacy in some patients with melanoma or lung cancer, but the lack of response in most cases presses the question of how general efficacy can be improved. In addressing this question, we generated a preclinical tumor model to study anti-PD-1 resistanc...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Cancer Res
Hoofdauteurs: Wang, Xiaohong, Schoenhals, Jonathan E, Li, Ailin, Valdecanas, David R, Ye, Huiping, Zhang, Fenglin, Tang, Chad, Krishnan, Sunil, Allison, James, Sharma, Padmanee, Hwu, Patrick, Komaki, Ritsuko, Overwijk, Willem, Gomez, Daniel R., Chang, Joe Y., Hahn, Stephen M., Cortez, Maria Angelica, Welsh, James W.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2016
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5875182/
https://ncbi.nlm.nih.gov/pubmed/27821490
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-15-3142
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items